Pharmaceutical Drug Delivery Market by Route of Administration (Oral Drug Delivery,Nasal Drug Delivery, Ocular Drug Delivery, Topical Drug Delivery, and Others), Application, End user and Region, Global trends and forecast from 2022 to 2029

Published on: Apr 2022
From:USD $3499.00
Number Of Pages:160

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 2.43 billion	5.5%	North America

by Type	by Application	by End User
Conventional Advanced	Cancer Diabetes Respiratory Diseases Cardiovascular Diseases Others	Hospital Pharmacies Retail Pharmacies

4.7/5 - (23 votes)

Pharmaceutical Drug Delivery Market Overview

The global pharmaceutical drug delivery market is expected to grow at 5.5% CAGR from 2022 to 2029. It is expected to reach above USD 2.43 billion by 2029 from USD 1.5 billion in 2020.

Pharmaceutical drug delivery encompasses the strategic administration of medications or therapeutic agents to attain specific therapeutic outcomes. This discipline entails the design and implementation of diverse methodologies, systems, and technologies to deliver drugs in a safe and efficient manner to targeted sites within the body. Its primary objectives include optimizing medication efficacy, mitigating potential adverse effects, enhancing drug bioavailability, and fostering patient adherence to treatment regimens. Conventional drug delivery modalities comprise oral administration (utilizing tablets, capsules, or liquid formulations), injectable delivery, transdermal administration (via patches), topical application (on the skin or mucous membranes), and other specialized approaches. These delivery systems facilitate precise and controlled drug administration to achieve therapeutic goals while prioritizing patient safety and convenience.

The growth trajectory of the pharmaceutical drug delivery industry is propelled by several factors, notably the escalating prevalence of chronic ailments such as cardiovascular diseases, diabetes, cancer, and respiratory disorders. Additionally, the evolution of sophisticated drug delivery systems and the proliferation of product launches by industry stakeholders contribute significantly to market expansion. Given the chronic nature of these conditions and the necessity for long-term management involving multiple medications, there is a growing impetus to develop advanced drug delivery systems to optimize treatment efficacy. Notably, the refinement of inhalation products featuring enhanced drug delivery mechanisms for the management of asthma and chronic obstructive pulmonary disease (COPD) has garnered considerable attention in recent years.

Moreover, ongoing advancements in drug delivery technologies serve as a key driver of market growth. For instance, the utilization of liposomal drug delivery systems exemplified by Doxil (liposomal doxorubicin) has demonstrated efficacy in cancer treatment, effectively improving drug efficacy while minimizing adverse effects. Similarly, the application of nanotechnology and nanocarriers has revolutionized drug delivery by bolstering drug stability, solubility, and targeted delivery.

Pharmaceutical Drug Delivery Market | Exactitude Consultancy

Pharmaceutical Drug Delivery Market Segment Analysis

The global pharmaceutical drug delivery market is segmented based on by route of administration, application, type, end user and Region. Based on route of administration, the pharmaceutical drug delivery Market is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, nasal drug delivery, ocular drug delivery, topical drug delivery, and others. The injectable segment is estimated to dominate the drug delivery market share owing to the system’s ability to deliver drugs to the target site allowing it to be more localized. Also, rising patient preference shift from vial-and-syringe to ready to-use devices to boost the segment growth.

Based on the applications, the pharmaceutical drug delivery market is segmented into cancer, diabetes, respiratory diseases, cardiovascular diseases, and others. Based on the application, the cancer segment dominated the global pharmaceutical drug delivery devices market in 2020. This is attributable to the rising prevalence of cancer among the population. On the other hand, the cardiovascular segment is estimated to be the fastest-growing segment during the forecast period. This is attributed to the rising focus of the pharmaceutical companies towards the development of drugs for curing cardiovascular diseases

Based on the type, the pharmaceutical drug delivery market is segmented into conventional and advanced. Based on type, the market has been segmented into conventional and advanced. Conventional drug delivering systems account for the dominating share in the market. Also, the increasing prevalence of respiratory diseases, growing hospital admissions, and demand for needle-free drug delivery devices are the factors responsible for the leading position. On the flip side, innovations for nanotechnology-based devices are emerging in the market. Demand for more user-friendly, compatible, and lesser side effects devices are expected to propel the demand for advanced medication delivery in the market.

Based on end user, the pharmaceutical drug delivery market is segmented hospital pharmacies, retail pharmacies. The hospitals segment accounted largest revenue share in 2020. This is attributed to the higher penetration of the private and public hospitals across the global. The rising investments by the government and the corporate sector in the development of the advanced hospitals have propelled the growth of this segment. On the other hand, the home healthcare segment is estimated to be the most opportunistic market during the forecast period. The growing geriatric population, rising personal disposable income, rising awareness regarding hospital acquired infections, and rising healthcare expenditure are the major factors that are expected to drive the growth of the home healthcare segment.

Pharmaceutical Drug Delivery Market Players

The Pharmaceutical drug delivery market key players include Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, 3M Company, Pfizer Inc., and Sanofi.

Recent Developments

On July 14, 2022, the Food and Drug Administration approved crizotinib (Pfizer Inc.) for adult and pediatric patients 1 year of age and older with unresectable, recurrent, or refractory inflammatory anaplastic lymphoma kinase (ALK)-positive myofibroblastic tumors (IMT).

Who Should Buy? Or Key stakeholders

Healthcare IT industries.
Healthcare
Institutional & retail players.
Investment research firms
Others.

The global pharmaceutical drug delivery market is expected to grow at 5.5% CAGR
Based on the application, the cancer segment dominated the global pharmaceutical drug delivery devices market.
Based on the type, conventional drug delivering systems account for the dominating share in the market.
Based on end user, the hospitals segment accounted largest revenue share.
North America is projected to dominate the global pharmaceutical drug delivery market.
The major trend in the Pharmaceutical Drug Delivery Market is the increasing adoption of advanced drug delivery technologies for targeted and personalized treatments.

Pharmaceutical Drug Delivery Market Regional Analysis

The pharmaceutical drug delivery market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

North America is projected to dominate the global pharmaceutical drug delivery market from 2021 to 2031. This is attributed to increase in incidence of chronic diseases such as cancer, diabetic, and respiratory disorders; presence of large number of players, innovation in drug delivery, and government funding for research on life sciences. Additionally, growth of the pharmaceutical & biotechnology industries and presence of well-built and high-quality infrastructure for laboratory and clinical research propel the market in North America. The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period due to rise in research & developmental activities, increase in government initiatives for improving health care, and surge in focus of key players in building or strengthening presence in the region.

Europe holds the second position in the global market. Increasing prevalence of chronic diseases is the major factor responsible to drive the European market growth. This, coupled with the penetration of big pharma companies in countries such as Italy, Switzerland, Ireland, and others is expected to drive this market growth.

Key Market Segments: Pharmaceutical drug delivery Market

Pharmaceutical Drug Delivery Market by Type, 2020-2029, (USD Million), (Thousand Units)

Conventional
Advanced

Pharmaceutical Drug Delivery Market by Application, 2020-2029, (USD Million), (Thousand Units)

Cancer
Diabetes
Respiratory Diseases
Cardiovascular Diseases
Others

Pharmaceutical Drug Delivery Market by Route of Administration, 2020-2029, (USD Million), (Thousand Units)

Oral Drug Delivery
Pulmonary Drug Delivery
Injectable Drug Delivery
Nasal Drug Delivery
Ocular Drug Delivery
Topical Drug Delivery
Others

Pharmaceutical Drug Delivery Market by End User, 2020-2029, (USD Million), (Thousand Units)

Hospital Pharmacies
Retail Pharmacies

Pharmaceutical Drug Delivery Market by Region, 2020-2029, (USD Million), (Thousand Units)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries In All Regions Are Covered.

INTRODUCTION
1. MARKET DEFINITION
2. MARKET SEGMENTATION
3. RESEARCH TIMELINES
4. ASSUMPTIONS AND LIMITATIONS
RESEARCH METHODOLOGY
1. DATA MINING
  1. SECONDARY RESEARCH
  2. PRIMARY RESEARCH
  3. SUBJECT-MATTER EXPERTS’ ADVICE
2. QUALITY CHECKS
  1. FINAL REVIEW
3. DATA TRIANGULATION
  1. BOTTOM-UP APPROACH
  2. TOP-DOWN APPROACH
  3. RESEARCH FLOW
4. DATA SOURCES
EXECUTIVE SUMMARY
MARKET OVERVIEW
1. GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET OUTLOOK
  1. MARKET DRIVERS
  2. MARKET RESTRAINTS
  3. MARKET OPPORTUNITIES
2. IMPACT OF COVID-19 ON PHARMACEUTICAL DRUG DELIVERY MARKET
3. PORTER’S FIVE FORCES MODEL
  1. THREAT FROM NEW ENTRANTS
  2. THREAT FROM SUBSTITUTES
  3. BARGAINING POWER OF SUPPLIERS
  4. BARGAINING POWER OF CUSTOMERS
  5. DEGREE OF COMPETITION
4. INDUSTRY VALUE CHAIN ANALYSIS
GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE
1. CONVENTIONAL
2. ADVANCED
GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY END-USE INDUSTRY
1. HOSPITAL PHARMACIES
2. RETAIL PHARMACIES
GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION
1. CANCER
2. DIABETES
3. RESPIRATORY DISEASES
4. CARDIOVASCULAR DISEASES
5. OTHERS
GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION
1. ORAL DRUG DELIVERY
2. PULMONARY DRUG DELIVERY
3. INJECTABLE DRUG DELIVERY
4. NASAL DRUG DELIVERY
5. OCULAR DRUG DELIVERY
6. TOPICAL DRUG DELIVERY
7. OTHERS
GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY REGION
1. NORTH AMERICA
  1. US
  2. CANADA
  3. MEXICO
2. SOUTH AMERICA
  1. BRAZIL
  2. ARGENTINA
  3. COLOMBIA
  4. CHILE
  5. REST OF SOUTH AMERICA
3. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. RUSSIA
  7. NETHERLANDS
  8. BELGIUM
  9. REST OF EUROPE
4. ASIA PACIFIC
  1. INDIA
  2. CHINA
  3. JAPAN
  4. SOUTH KOREA
  5. AUSTRALIA
  6. NEW ZEALAND
  7. INDONESIA
  8. TAIWAN
  9. MALAYSIA
  10. REST OF ASIA PACIFIC
5. MIDDLE EAST AND AFRICA
  1. UAE
  2. SAUDI ARABIA
  3. SOUTH AFRICA
  4. REST OF MIDDLE EAST AND AFRICA

COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
1. BAYER AG
2. BECTON
3. DICKINSON AND COMPANY
4. HOFFMANN-LA ROCHE AG
5. GLAXOSMITHKLINE PLC
6. JOHNSON & JOHNSON
7. MERCK & CO., INC.
8. NOVARTIS AG
9. 3M COMPANY
10. PFIZER INC.
11. SANOFI *THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 2 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 3 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 4 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 5 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 6 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 7 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 8 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 9 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY REGION (USD MILLIONS), 2020-2029

TABLE 10 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY REGION (THOUSAND UNITS), 2020-2029

TABLE 11 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 12 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 13 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 14 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 15 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 16 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 17 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 18 NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 19 US PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 20 US PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 21 US PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 22 US PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 23 US PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 24 US PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 25 US PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 26 US PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 27 CANADA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (MILLIONS), 2020-2029

TABLE 28 CANADA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 29 CANADA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 30 CANADA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 31 CANADA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 32 CANADA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 33 CANADA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 34 CANADA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 35 MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 36 MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 37 MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 38 MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 39 MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 40 MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 41 MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 42 MEXICO PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 43 SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 44 SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 45 SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 46 SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 47 SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 48 SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 49 SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 50 SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 51 BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 52 BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 53 BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 54 BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 55 BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 56 BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 57 BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 58 BRAZIL PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 59 ARGENTINA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 60 ARGENTINA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 61 ARGENTINA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 62 ARGENTINA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 63 ARGENTINA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 64 ARGENTINA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 65 ARGENTINA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 66 ARGENTINA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 67 COLOMBIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 68 COLOMBIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 69 COLOMBIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 70 COLOMBIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 71 COLOMBIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 72 COLOMBIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 73 COLOMBIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 74 COLOMBIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 75 REST OF SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 76 REST OF SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 77 REST OF SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 78 REST OF SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 79 REST OF SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 80 REST OF SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 81 REST OF SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 82 REST OF SOUTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 83 ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 84 ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 85 ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 86 ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 87 ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 88 ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 89 ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 90 ASIA-PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 91 INDIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 92 INDIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 93 INDIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 94 INDIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 95 INDIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 96 INDIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 97 INDIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 98 INDIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 99 CHINA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 100 CHINA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 101 CHINA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 102 CHINA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 103 CHINA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 104 CHINA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 105 CHINA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 106 CHINA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 107 JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 108 JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 109 JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 110 JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 111 JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 112 JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 113 JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 114 JAPAN PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 115 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 116 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 117 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 118 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 119 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 120 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 121 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 122 SOUTH KOREA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 123 AUSTRALIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 124 AUSTRALIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 125 AUSTRALIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 126 AUSTRALIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 127 AUSTRALIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 128 AUSTRALIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 129 AUSTRALIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 130 AUSTRALIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 131 SOUTH EAST ASIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 132 SOUTH EAST ASIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 133 SOUTH EAST ASIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 134 SOUTH EAST ASIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 135 SOUTH EAST ASIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 136 SOUTH EAST ASIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 137 SOUTH EAST ASIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 138 SOUTH EAST ASIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 139 REST OF ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 140 REST OF ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 141 REST OF ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 142 REST OF ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 143 REST OF ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 144 REST OF ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 145 REST OF ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 146 REST OF ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 147 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 148 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 149 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 150 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 151 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 152 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 153 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 154 EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 155 GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 156 GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 157 GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 158 GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 159 GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 160 GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 161 GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 162 GERMANY PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 163 UK PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 164 UK PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 165 UK PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 166 UK PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 167 UK PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 168 UK PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 169 UK PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 170 UK PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 171 FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 172 FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 173 FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 174 FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 175 FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 176 FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 177 FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 178 FRANCE PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 179 ITALY PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 180 ITALY PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 181 ITALY PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 182 ITALY PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 183 ITALY PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 184 ITALY PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 185 ITALY PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 186 ITALY PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 187 SPAIN PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 188 SPAIN PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 189 SPAIN PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 190 SPAIN PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 191 SPAIN PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 192 SPAIN PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 193 SPAIN PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 194 SPAIN PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 195 RUSSIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 196 RUSSIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 197 RUSSIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 198 RUSSIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 199 RUSSIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 200 RUSSIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 201 RUSSIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 202 RUSSIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 203 REST OF EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 204 REST OF EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 205 REST OF EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 206 REST OF EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 207 REST OF EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 208 REST OF EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 209 REST OF EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 210 REST OF EUROPE PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 211 MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 212 MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 213 MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 214 MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 215 MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 216 MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 217 MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 218 MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 219 UAE PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 220 UAE PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 221 UAE PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 222 UAE PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 223 UAE PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 224 UAE PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 225 UAE PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 226 UAE PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 227 SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 228 SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 229 SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 230 SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 231 SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 232 SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 233 SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 234 SAUDI ARABIA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 235 SOUTH AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 236 SOUTH AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 237 SOUTH AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 238 SOUTH AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 239 SOUTH AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 240 SOUTH AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 241 SOUTH AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 242 SOUTH AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

TABLE 243 REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (USD MILLIONS), 2020-2029

TABLE 244 REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION (THOUSAND UNITS), 2020-2029

TABLE 245 REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (USD MILLIONS), 2020-2029

TABLE 246 REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE (THOUSAND UNITS), 2020-2029

TABLE 247 REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (USD MILLIONS), 2020-2029

TABLE 248 REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION (THOUSAND UNITS), 2020-2029

TABLE 249 REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (USD MILLIONS), 2020-2029

TABLE 250 REST OF MIDDLE EAST AND AFRICA PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER (THOUSAND UNITS), 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY TYPE, USD MILLION, 2020-2029

FIGURE 9 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, USD MILLION, 2020-2029
FIGURE 10 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY APPLICATION, USD MILLION, 2020-2029

FIGURE 11 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY END USER, USD MILLION, 2020-2029

FIGURE 12 GLOBAL PHARMACEUTICAL DRUG DELIVERY MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 13 PORTER’S FIVE FORCES MODEL

FIGURE 14 MARKET SHARE ANALYSIS

FIGURE 15 BAYER AG: COMPANY SNAPSHOT

FIGURE 16 BECTON: COMPANY SNAPSHOT

FIGURE 17 DICKINSON AND COMPANY: COMPANY SNAPSHOT

FIGURE 18 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT

FIGURE 19 GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT

FIGURE 20 JOHNSON & JOHNSON: COMPANY SNAPSHOT

FIGURE 21 MERCK & CO., INC.: COMPANY SNAPSHOT

FIGURE 22 NOVARTIS AG: COMPANY SNAPSHOT

FIGURE 23 3M COMPANY: COMPANY SNAPSHOT

FIGURE 24 PFIZER INC.: COMPANY SNAPSHOT

FIGURE 25 SANOFI: COMPANY SNAPSHOT

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT

Pharmaceutical Drug Delivery Market Overview

Pharmaceutical Drug Delivery Market Segment Analysis

Pharmaceutical Drug Delivery Market Players

Who Should Buy? Or Key stakeholders

Pharmaceutical Drug Delivery Market Regional Analysis

Key Market Segments: Pharmaceutical drug delivery Market

Table of Content

LIST OF TABLES

LIST OF FIGURES

DOWNLOAD FREE SAMPLE REPORT

Inquire for Discount

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

6 Elmore Road, Luton, Bedfordshire LU20QB, UK

Plot No. 39, SR, 10-16, NDA Pashan Rd, Bavdhan, Pune, Maharashtra 411021

Subscribe our newsletter

Pharmaceutical Drug Delivery Market by Route of Administration (Oral Drug Delivery,Nasal Drug Delivery, Ocular Drug Delivery, Topical Drug Delivery, and Others), Application, End user and Region, Global trends and forecast from 2022 to 2029

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT

Pharmaceutical Drug Delivery Market Overview

Pharmaceutical Drug Delivery Market Segment Analysis

Pharmaceutical Drug Delivery Market Players

Who Should Buy? Or Key stakeholders

Pharmaceutical Drug Delivery Market Regional Analysis

Key Market Segments: Pharmaceutical drug delivery Market

Table of Content

LIST OF TABLES

LIST OF FIGURES

Related Reports

DOWNLOAD FREE SAMPLE REPORT

Inquire for Discount

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure